To test the effectiveness of inhibiting the TGF-β signalling pathway on in vivo tumour growth and metastasis, we developed EC cell-derived xenograft mouse models by intraperitoneal injection of IshikawaLuc or MFE-296Luc cells in immunocompromised mice (Figure 6A). This evidence concerns the gene TGFB1 and neoplasm.